Associate Director, New Product Planning

Rapport TherapeuticsBoston, MA
$205,000 - $225,000Hybrid

About The Position

The Associate Director, New Product Planning is a key member of cross-functional program teams, providing market insights, research, and analysis to inform the commercial strategy for pipeline assets from early discovery and clinical development through launch readiness. This individual will conduct market research and build rigorous forecasts, lead commercial opportunity assessments, and translate clinical, scientific, and market data into actionable strategic recommendations for senior leadership and cross-functional stakeholders. The ideal candidate combines strong analytical and financial modeling skills with strategic business judgment, and thrives in ambiguous, fast-moving environments typical of early-stage assets.

Requirements

  • Bachelor's degree required
  • 5+ years of relevant experience in pharmaceutical/biotech commercial strategy, new product planning, or life sciences management consulting
  • Demonstrated expertise in building and defending complex forecasting models (Excel-based; familiarity with forecasting software a plus)
  • Strong track record of leading or contributing to commercial opportunity assessments, market sizing, and competitive intelligence analyses
  • Life science consulting experience (e.g., strategy consulting, commercial due diligence, or pharma-focused advisory) strongly preferred
  • Excellent analytical, quantitative, and financial modeling skills
  • Strong executive presence with the ability to communicate complex data clearly to senior leadership
  • Experience working cross-functionally across R&D, Medical, Commercial, and Finance

Nice To Haves

  • MBA, MPH, or advanced life sciences degree is a plus
  • Therapeutic area experience in neurology and/or psychiatry is a plus

Responsibilities

  • Build, maintain, and continuously refine multi-year commercial forecasts (epidemiology-based and analog-based) for pipeline assets across multiple indications and geographies
  • Develop patient flow, market share, and pricing/access models to support investment decisions, licensing evaluations, and portfolio prioritization
  • Stress-test forecast assumptions through sensitivity analyses and scenario planning; clearly communicate key drivers, risks, and uncertainty ranges
  • Lead end-to-end opportunity assessments for early- and mid-stage pipeline assets, including market sizing, competitive landscape analysis, unmet need evaluation, and target product profile (TPP) development through combination of primary and desktop research, and manage primary market research (physician, patient, payer) to inform positioning and forecast assumptions; manage relationships with external vendors/consultants
  • Partner with Discovery, Medical, Clinical Development, Regulatory, and Market Access to evaluate indication sequencing, target population definition, and differentiation strategy
  • Synthesize primary and secondary market research (KOL interviews, payer/provider surveys, syndicated data) into clear quantitative and qualitative outputs to guide investment and program-level decisions
  • Support in-licensing, out-licensing, and M&A due diligence with commercial assessments and valuation inputs
  • Prepare materials for governance forums (portfolio reviews, program committees, board updates), presenting complex analyses in a clear, concise, and decision-ready format
  • Contribute to long-range portfolio planning, identifying lifecycle opportunities, and informing R&D prioritization. Subject matter expert on market dynamics, TPP, and associated revenue opportunity for assigned programs.
  • Partner closely with R&D program teams to provide commercial input into program-level decision models (e.g., go/no-go criteria, indication sequencing, trial design trade-offs, target product profile refinement), ensuring commercial assumptions and market realities are reflected in development strategy
  • Represent the commercial perspective on program teams and governance forums, translating clinical development scenarios into commercial implications (revenue impact, competitive positioning, market access considerations) to inform R&D investment decisions
  • Serve as a thought partner to Discovery, Development, Finance, and future Commercial teams throughout asset lifecycle planning
  • Experienced in managing relationships with external vendors and consultants supporting market research and forecasting workstreams

Benefits

  • unlimited PTO
  • a lifestyle spending account
  • commuting reimbursement
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service